Clinical Trial Update: Optimization for the Treatment of Advanced Pulmonary Large Cell Neuroendocrine Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update discusses optimization of treatment for advanced pulmonary large cell neuroendocrine carcinoma. The current study status is list…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Large-cell Neuroendocrine Carcinoma

Snippet

Sponsor: Shanghai Chest Hospital | Conditions: Pulmonary Large Cell Neuroendocrine Carcinoma | Phase 2 | Status: UNKNOWN